Some women with breast cancer are calling it quits with their aromatase inhibitor

June 2007

Some women with breast cancer are calling it quits with their aromatase inhibitor...Arimidex, Aromasin, and Femara.

Aromatase inhibitors work better than tamoxifen to prevent recurrence of estrogen-receptor positive breast cancer in postmenopausal women.

And they were initially thought to be better tolerated.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote